Why GLP-1s are Biologically Plausible for Alzheimers Beyond lowering glucose and weight, GLP-1 signaling appears to: Improve insulin signaling in the brain Dampen neuroinflammation (microglial activation) Reduce oxidative stress Interact with amyloid- and tau pathways in preclinical models Recent peer-reviewed reviews synthesize these mechanisms and frame GLP-1s as potential multi-target neuroprotective agents rather than single-pathway drugs
Just from a practical point of view, he is an absolute joy to interview, no baggy filler words, his voice as clear as a bell
This study moves beyond singledisease models to embrace the clinical reality of multimorbidity
Milk-derived exosomes for oral delivery of Paclitaxel
Suspiciously low prices: While compounded medications are legitimately more affordable than brand-name versions, prices that seem too good to be true may indicate quality concerns
Consequently, higher concentrations of sulforaphane are necessary to induce cell cycle arrest and apoptosis, which are desirable outcomes in a chemotherapeutic context of inhibition
